Medication info
Megaclober Tablets (Acyclovir)

Megaclober Tablets (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
L&C Bio Co., Ltd.
Appearance
Light blue round tablets
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 202000180 · Approved 2020.01.13 · Insurance code 060500220

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, administration is preferable at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically stop treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, for example by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the accumulated dose resulting from intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Child administration
1) Age 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per dose per kg of body weight (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Ingredients

Manufacturer
L&C Bio Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infection of skin and mucosal tissues
  • herpes zoster virus infection
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat herpes simplex virus infections, including primary and recurrent genital herpes, and herpes zoster virus infections. It is particularly effective for alleviating acute pain associated with herpes zoster. Additionally, it is used in the treatment of chickenpox in children over 2 years old. This drug helps improve symptoms in patients suffering from various skin and mucosal diseases due to viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, administration is preferable at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically stop treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, for example by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the accumulated dose resulting from intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Child administration

1) Age 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per dose per kg of body weight (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Precautions

This medication should not be used in patients who have had allergic reactions to this drug, its components, or valaciclovir. Patients with impaired renal function may experience neuropsychiatric adverse effects more easily when using this medication, so caution is advised. Patients with compromised liver function should be administered this medication carefully, as there is a risk of further deterioration in liver function. Infants and children should use this medication with extra caution, and it is advisable to use the minimum necessary dose. Elderly patients may have decreased renal function, which can increase blood levels of this medication and result in more frequent adverse reactions; therefore, the dosage and administration intervals should be adjusted accordingly. During treatment with this medication, serious allergic reactions, such as anaphylactic shock, can rarely occur. If symptoms such as low blood pressure, difficulty breathing, or tightness in the chest appear, administration should be stopped immediately and medical assistance sought. Skin reactions, such as rashes, fever, blisters, and urticaria, can occur. If these symptoms arise, administration should be discontinued and appropriate treatment initiated. Alopecia, severe dermatitis, and syndromes that cause significant damage to the skin and mucosal membranes may develop, so skin status should be monitored closely. Various neuropsychiatric symptoms, including confusion, hallucinations, seizures, drowsiness, anxiety, and movement disorders, may occur, particularly in the elderly and patients with renal impairment, so monitoring for these symptoms is important. This medication may affect renal function, leading to renal failure or symptomatic urinary abnormalities; therefore, it is essential to regularly check urine status and renal function. Blood-related symptoms such as leukopenia, bleeding, and anemia may develop, necessitating blood tests to monitor the condition. Liver function abnormalities may result in hepatitis, jaundice, or elevated liver enzyme levels, so liver health should be monitored carefully. Gastrointestinal symptoms such as gastritis, nausea, vomiting, and abdominal pain may occur; if symptoms are severe, treatment should be stopped, and medical advice sought. Systemic symptoms such as fever, swelling, weakness, and headache can occur, so monitoring overall health is crucial. Muscle or joint pain may occur; if discomfort persists, it should be reported. Cardiac symptoms such as arrhythmias, chest pain, and fluctuations in blood pressure may appear, necessitating monitoring of heart status. Difficulty in urination or urinary obstruction can appear rarely; if there are difficulties in passing urine, medical advice should be sought. This medication is used for treating simple herpes, chickenpox, and herpes zoster. If symptoms do not improve or worsen, alternative treatments should be considered. Treatment is most effective when started early during the onset of symptoms; for herpes zoster, treatment should begin within 5 days of the onset of skin symptoms, and for chickenpox, within 3 days. Patients with immunocompromised functions should consider intravenous administration forms for treatment. During administration of this medication, especially at high doses, ensuring adequate fluid intake is essential to reduce the risk of dehydration and nephrotoxicity. In the case of recurrent genital herpes treatment, the necessity to continue after one year of administration should be reviewed. This medication may cause drowsiness or consciousness disturbances, so caution is advised when driving or operating dangerous machinery, especially for patients with renal impairment. Interactions with other medications can occur; particularly when used concurrently with drugs affecting renal function or certain other medications, consultation with a healthcare professional is recommended. Pregnant women or those likely to become pregnant should carefully consider the risks and benefits of using this medication, and during breastfeeding, discontinuation is necessary as this drug's components are transferred in breast milk. The safety of this medication in children or infants has not been fully established, so it should only be used cautiously when absolutely necessary. Elderly patients should use this medication cautiously, adjusting the dose and administration intervals due to possible prolonged drug retention in the body, with a need for adequate fluid intake. In the event of overdose, severe symptoms such as agitation, stupor, seizures, and somnolence may occur; immediate hospitalization and appropriate treatment are necessary, including possible blood dialysis.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • chest tightness
  • phototoxic reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 118 more
  • hives-like erythema
  • hives
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • loss of coordination
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • speaking to oneself
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver impairment
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • decreased appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • malaise
  • generalized fatigue
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • lowered blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • convulsions
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to prevent exposure to air or moisture, and it is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage maintains the drug's effectiveness and ensures safety in use.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.